EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS

Kaliane Caldas de Brito iD, Miralba Freire de Carvalho Ribeiro da Silva, Cristiane Wanderley Cardoso, Luciano Kalabric Silva, Ricardo Khouri, Antônio Eduardo de Albuquerque Junior iD, Nelzair Araújo Vianna, Maria da Conceição Chagas de Almeida, Edson Duarte Moreira Junior iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319646 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2025. Verfasst von Kaliane Caldas de Brito und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, HIV Infections, Vaccination. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Oswaldo Cruz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human papillomavirus (HPV) causes several cancers that disproportionally affect people living with HIV/AIDS (PLWH) yet there is a paucity of research on interventions to foster HPV vaccine use in this population. We sought to evaluate the efficacy of a web-based, tailored intervention (e-HPV) to promote HPV vaccination among PLWH.

Methods

This is a randomized controlled trial with PLWH aged 18 to 45 years. Participants were recruited between January and June 2022 and randomized into two groups: experimental group (e-HPV), which received information about HPV and the HPV vaccine, based on the Protection Motivation Theory and control group, who received a clipping of information from the page maintained by the Ministry of Health dedicated to informing the population about HPV and the HPV vaccine. The primary and secondary outcomes were the percentage of PLWH willing to get HPV vaccine and HPV vaccine initiation (i.e., receipt of any doses by PLWH), respectively.

Results

A total of 654 individuals were randomly allocated: 327 in the e-HPV and 327 in the control group. The average age was 29.7 years, the majority were men (71.4%), black or mixed race (63.2%). The intention to get vaccinated against HPV was approximately twice as high among participants in the e-HPV vs. control group (OR = 2.0, 95% CI: 1.3–3.4; p < 0.003), and HPV vaccine initiation was also significantly more common among participants in the e-HPV group (OR = 2.1, 95% CI: 1.1-4.0; p = 0.03). Belief in the effectiveness of the HPV vaccine, risk perception and the severity of an HPV infection were the reasons most reported by participants intending to get HPV vaccination.

Conclusions

The intervention was acceptable and efficacious in increasing HPV vaccination among PLWH. Future studies are warranted to optimize and disseminate the e-HPV intervention to settings providing services to PLWH.

Trial registration

Brazilian Clinical Trials Registry RBR -557mbvy

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesPapillomavirus InfectionsHIV InfectionsVaccinationInternet-Based InterventionAcquired Immunodeficiency SyndromeHumansAdultFemaleMaleAdolescentMiddle AgedYoung AdultInternetHealth Knowledge, Attitudes, PracticePatient Acceptance of Health CareHuman Papillomavirus Viruses

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador, Bahia, Brazil.
  • Assistência e Pesquisa, Centro Estadual Especializado em Diagnóstico, Salvador, Bahia, Brazil.
  • Secretaria Municipal da Saúde, Salvador, Bahia, Brazil.
  • Clinical Research Center, Charitable Works Foundation of Sister Dulce, Salvador, Bahia, Brazil.

ORCID-Profile: Kaliane Caldas de Brito, Antônio Eduardo de Albuquerque Junior, Edson Duarte Moreira Junior

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Oswaldo Cruz

Zitieren

APA

de Brito, K. C., da Silva, M. F. C. R., Cardoso, C. W., Silva, L. K., Khouri, R., de Albuquerque Junior, A. E., Vianna, N. A., Almeida, M. D. C. C., & Moreira Junior, E. D. (2025). A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS. PLOS ONE. https://doi.org/10.1371/journal.pone.0319646

Vancouver

de Brito KC, da Silva MFCR, Cardoso CW, Silva LK, Khouri R, de Albuquerque Junior AE, et al. A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS. PLOS ONE. 2025. doi:10.1371/journal.pone.0319646

BibTeX
@article{deBrito2025,
  author = {de Brito, Kaliane Caldas and da Silva, Miralba Freire de Carvalho Ribeiro and Cardoso, Cristiane Wanderley and Silva, Luciano Kalabric and Khouri, Ricardo and de Albuquerque Junior, Antônio Eduardo and Vianna, Nelzair Araújo and Almeida, Maria da Conceição Chagas de and Moreira Junior, Edson Duarte},
  title = {A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319646}
}
Kostenlos starten →